An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

Wellfa, a fast-growing Direct-to-Consumer (D2C) brand from Advanced Enzymes Technologies Ltd. renowned for its commitment to ...

An uptick in digestive disorders such as lactose intolerance across the globe is fueling the demand for lactase-based products. Additionally, the increasing trend of clean-label and fortified foods is ...

MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, ...

Sharjah Airport International Free Zone (SAIF Zone) has further strengthened its position as a premier destination for ...

Researchers at the Manchester Institute of Biotechnology (MIB) have demonstrated how genetically engineered enzymes can ...

May is Cystic Fibrosis Awareness Month - learn about this genetic condition causing thick mucus and organ damage.

This breakthrough could lead to cleaner, more efficient ways of making medicines and other important chemicals, all while ...

Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...

Researchers from the Access to Advanced Health Institute and collaborating institutions have developed a promising new bivalent vaccine candidate that can protect against both yellow fever and Zika ...

N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier ...

Learn more about how fungi inside of us may hold the key to curing fatty liver disease.